Description du projet
Autonomisation des patients porteurs du VIH grâce à une plateforme de santé mobile d’autogestion
Les progrès de la numérisation et de l’internet des objets ont stimulé l’innovation dans divers secteurs. Dans le domaine des soins de santé, ces avancées ont le potentiel d’améliorer la personnalisation des soins aux patients et de fournir des soins médicaux plus efficaces et plus précis. L’intégration de ces technologies dans les soins de santé reste cependant limitée, principalement à des niveaux inférieurs et par quelques prestataires. Dans ce contexte, le projet EmERGE, financé par l’UE, s’est fixé pour objectif de développer une plateforme de santé mobile révolutionnaire. Celle-ci devrait permettre aux patients porteurs du VIH et dont la maladie est stable de gérer eux-mêmes leur état de santé. Des prestataires de soins de santé en Espagne et au Royaume-Uni exploiteront cette plateforme, en s’appuyant sur les solutions de santé mobile existantes. Sa mise en œuvre apportera un soutien crucial et permettra aux patients de toute l’UE d’entrer en contact avec des médecins.
Objectif
EmERGE will develop a mHealth platform to enable self-management of HIV in patients with stable disease. The platform will build upon and integrate the existing mHealth solutions operated by pioneering healthcare providers in the UK and Spain and apply a rigorous co-design approach to ensure patient and clinician input to the solution. The platform will provide users with web based and mobile device applications which interface securely with relevant medical data and facilitate remote access to key healthcare providers EATG, the European HIV patient organisation, will provide a direct and deep interaction with representative patients and clinicians from 5 EU countries. The platform and interfaces will be validated in a large study of 3900 patients using a tailored HTA process, MAST, specifically developed for the assessment of mHealth solutions including translatability as a key factor. Based on prior work showing a high uptake rate and use of mHealth in HIV patient populations, EmERGE aims to demonstrate the benefits to patients and simultaneous increases in cost-effectiveness for healthcare providers by reducing face-to-face consultations, estimated at 6000 saved per year within this study alone. Patient reported outcomes will be agreed and used in the assessment and development of the system which also aims to increase adherence and enable frailty to be reported using mHealth technology. Innovation will be given priority from the beginning by developing new business models of care provision, targeting key stakeholders in the EU health provider sector, including policymakers and clinicians, while eliciting demand from patients to highlight and initiate the widespread implementation and compensation of mHealth solutions within the timeframe of the project. Guidelines and policy briefs will be produced to evidence the benefits and disseminate the lessons learned to support the uptake of mHealth for self-management of other chronic diseases.
Champ scientifique
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV
- social scienceseconomics and businessbusiness and managementbusiness models
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsmobile phones
- social scienceseconomics and businesseconomicshealth economics
Programme(s)
Régime de financement
RIA - Research and Innovation actionCoordinateur
BN2 5BE Brighton
Royaume-Uni